# Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes

> **NCT01845831** · PHASE4 · COMPLETED · sponsor: **Emory University** · enrollment: 292 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Sitagliptin
- **DRUG:** Basal Bolus
- **DRUG:** Metformin and Sitagliptin
- **DRUG:** Glargine
- **DRUG:** Glargine 50%
- **DRUG:** Glargine 80%

## Key facts

- **NCT ID:** NCT01845831
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 292 (ACTUAL)
- **Last updated:** 2017-05-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01845831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01845831, "Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01845831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*